193 related articles for article (PubMed ID: 32458599)
21. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Yao X; Ye F; Zhang M; Cui C; Huang B; Niu P; Liu X; Zhao L; Dong E; Song C; Zhan S; Lu R; Li H; Tan W; Liu D
Clin Infect Dis; 2020 Jul; 71(15):732-739. PubMed ID: 32150618
[TBL] [Abstract][Full Text] [Related]
22. Antiviral therapy for coronavirus disease 2019.
Gong S; Su J; Yan X; Li F; Hu L; Liu S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):598-602. PubMed ID: 32879113
[TBL] [Abstract][Full Text] [Related]
23. Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal.
Khuroo MS
Int J Antimicrob Agents; 2020 Sep; 56(3):106101. PubMed ID: 32687949
[TBL] [Abstract][Full Text] [Related]
24. COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits.
Halm MA
Am J Crit Care; 2020 Nov; 29(6):489-492. PubMed ID: 32839815
[No Abstract] [Full Text] [Related]
25. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
Gao J; Hu S
Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583
[TBL] [Abstract][Full Text] [Related]
26. Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
Carradori S
Antiinflamm Antiallergy Agents Med Chem; 2020; 19(2):85-87. PubMed ID: 32213152
[No Abstract] [Full Text] [Related]
27. Repurposing old drugs as antiviral agents for coronaviruses.
Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
[TBL] [Abstract][Full Text] [Related]
28. Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of Coronavirus Disease-2019: Psychopharmacological Interactions and Neuropsychiatric Sequelae.
Hamm BS; Rosenthal LJ
Psychosomatics; 2020; 61(6):597-606. PubMed ID: 32800347
[TBL] [Abstract][Full Text] [Related]
29. [Chloroquine phosphate: therapeutic drug for COVID-19].
Mo L; Zheng P
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Apr; 40(4):586-594. PubMed ID: 32895128
[TBL] [Abstract][Full Text] [Related]
30. Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19.
Zou L; Dai L; Zhang X; Zhang Z; Zhang Z
Arch Pharm Res; 2020 Aug; 43(8):765-772. PubMed ID: 32740801
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivatives.
Zhang XL; Li ZM; Ye JT; Lu J; Ye LL; Zhang CX; Liu PQ; Duan DD
Acta Pharmacol Sin; 2020 Nov; 41(11):1377-1386. PubMed ID: 32968208
[TBL] [Abstract][Full Text] [Related]
32. The Use of "Novel Pharmacology" in the Treatment of COVID-19 and Potential Psychiatric Risks.
Yahya AS; Khawaja S; Chukwuma J
Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32441496
[No Abstract] [Full Text] [Related]
33. Novel approach for low-dose pulmonary delivery of hydroxychloroquine in COVID-19.
Fassihi SC; Nabar NR; Fassihi R
Br J Pharmacol; 2020 Nov; 177(21):4997-4998. PubMed ID: 32562278
[No Abstract] [Full Text] [Related]
34. Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action.
Khan Z; Karataş Y; Rahman H
Adv Ther; 2020 Jun; 37(6):2575-2579. PubMed ID: 32350686
[TBL] [Abstract][Full Text] [Related]
35. Trial of Chloroquines in the Treatment of COVID-19 and Its Research Progress in Forensic Toxicology.
Duan YJ; Liu Q; Zhao SQ; Huang F; Ren L; Liu L; Zhou YW
Fa Yi Xue Za Zhi; 2020 Apr; 36(2):157-163. PubMed ID: 32212512
[TBL] [Abstract][Full Text] [Related]
36. Targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19: Can it be a novel therapeutic strategy?
Kazama I
Drug Discov Ther; 2020 Jul; 14(3):143-144. PubMed ID: 32581194
[TBL] [Abstract][Full Text] [Related]
37. Chloroquine paradox may cause more damage than help fight COVID-19.
Sharma A
Microbes Infect; 2020; 22(4-5):154-156. PubMed ID: 32305500
[TBL] [Abstract][Full Text] [Related]
38. [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].
multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):185-188. PubMed ID: 32164085
[TBL] [Abstract][Full Text] [Related]
39. Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence.
Roustit M; Guilhaumou R; Molimard M; Drici MD; Laporte S; Montastruc JL;
Therapie; 2020; 75(4):363-370. PubMed ID: 32473812
[TBL] [Abstract][Full Text] [Related]
40. The friendly use of chloroquine in the COVID-19 disease: a warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene.
Capoluongo ED; Amato F; Castaldo G
Clin Chem Lab Med; 2020 Jun; 58(7):1162-1164. PubMed ID: 32333649
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
